These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31264797)

  • 61. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hippocampal Subregions Across the Psychosis Spectrum.
    Vargas T; Dean DJ; Osborne KJ; Gupta T; Ristanovic I; Ozturk S; Turner J; van Erp TGM; Mittal VA
    Schizophr Bull; 2018 Aug; 44(5):1091-1099. PubMed ID: 29272467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensorimotor gating, cannabis use and the risk of psychosis.
    Winton-Brown T; Kumari V; Windler F; Moscoso A; Stone J; Kapur S; McGuire P
    Schizophr Res; 2015 May; 164(1-3):21-7. PubMed ID: 25801237
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship of negative symptom severity with cognitive symptoms and functioning in subjects at ultra-high risk for psychosis.
    Üçok A; Direk N; Kaya H; Çağlar N; Çıkrıkçılı U; Noyan H; Yokuşoğlu Ç; Devrim-Üçok M
    Early Interv Psychiatry; 2021 Aug; 15(4):966-974. PubMed ID: 32945138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects.
    Ittig S; Studerus E; Papmeyer M; Uttinger M; Koranyi S; Ramyead A; Riecher-Rössler A
    Eur Psychiatry; 2015 Feb; 30(2):242-50. PubMed ID: 25555341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level.
    Pettersson-Yeo W; Benetti S; Marquand AF; Dell'acqua F; Williams SC; Allen P; Prata D; McGuire P; Mechelli A
    Psychol Med; 2013 Dec; 43(12):2547-62. PubMed ID: 23507081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study.
    Scala S; Pousada A; Stone WS; Thermenos HW; Manschreck TC; Tsuang MT; Faraone SV; Seidman LJ
    Schizophr Res; 2013 Mar; 144(1-3):122-8. PubMed ID: 23312552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia.
    Chung YS; Kang DH; Shin NY; Yoo SY; Kwon JS
    Schizophr Res; 2008 Feb; 99(1-3):111-8. PubMed ID: 18096371
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ; Harmsen EC; Koelman JH; Bour LJ; van Amelsvoort TA; Linszen DH; de Haan L; Nieman DH
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychological symptomatology and impaired prepulse inhibition of the startle reflex are associated with cannabis-induced psychosis.
    Morales-Muñoz I; Martínez-Gras I; Ponce G; de la Cruz J; Lora D; Rodríguez-Jiménez R; Jurado-Barba R; Navarrete F; García-Gutiérrez MS; Manzanares J; Rubio G
    J Psychopharmacol; 2017 Aug; 31(8):1035-1045. PubMed ID: 28648138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
    Simon AE; Grädel M; Cattapan-Ludewig K; Gruber K; Ballinari P; Roth B; Umbricht D
    Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.
    Swerdlow NR; Light GA; Thomas ML; Sprock J; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL
    Schizophr Res; 2018 Aug; 198():6-15. PubMed ID: 28549722
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals.
    Fornito A; Yung AR; Wood SJ; Phillips LJ; Nelson B; Cotton S; Velakoulis D; McGorry PD; Pantelis C; Yücel M
    Biol Psychiatry; 2008 Nov; 64(9):758-65. PubMed ID: 18639238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk.
    Kim HS; Shin NY; Jang JH; Kim E; Shim G; Park HY; Hong KS; Kwon JS
    Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis.
    Bang M; Kang JI; Kim SJ; Park JY; Kim KR; Lee SY; Park K; Lee E; Lee SK; An SK
    Schizophr Bull; 2019 Oct; 45(6):1279-1290. PubMed ID: 31220321
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
    Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis.
    Nordholm D; Jensen MA; Kristiansen J; Glenthøj LB; Kristensen TD; Wenneberg C; Hjorthøj C; Garde AH; Nordentoft M
    Schizophr Res; 2023 Apr; 254():218-226. PubMed ID: 36996675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.